New guidelines for stroke prevention from the American Stroke Association emphasize the benefits of GLP-1 drugs, a balanced ...

Amgen’s next-generation cholesterol drug has shown it can reverse the build up of plaque build-up in coronary arteries which can lead to a heart attack or stroke. The company’s Repatha ...

Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.

Amgen AMGN will report third-quarter 2024 results on Oct. 30, after market close. In the last reported quarter, the company ...

The research, compiled by the European Social Insurance Platform (ESIP) and the Medicine Evaluation Committee (MEDEV) and ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach. By Ellen Barry and Christina Jewett The Food and Drug Administration on ...

And while there are many medications out there to help people cope with pain, they can often cause their own headaches, to say the very least. Now a pharmaceutical company is potentially on the ...

Drug-induced lupus is more common in men because they are given these drugs more often; however, not everyone who takes these drugs will develop the disease. Specific criteria for diagnosing ...

A team has designed a new drug against malaria and identified its mechanism of action. In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent ...

Other signs of renewed pharma innovation include the approval by the European Commission this week of Amgen’s Repatha drug, which was shown in clinical trials to reduce “bad cholesterol” by ...

The drug made $1.63 billion in sales last year ... though did not say that there was any direct connection to Repatha. The spokesperson added that this is an “extension of our LDL-C testing ...